PATENT CLAIM ANALYSIS

Application Number: 16072291
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-12
Patent Classification: ["514", "146000"]

Abstract:
The present invention is directed to novel cytotoxic tubulysin analogs and derivatives, to antibody drug conjugates thereof, and to methods for using the same to treat medical conditions including cancer.

Claim (Index 23):
The compound or salt of any of  claims 5 - 7 , wherein AB is attached to L through a cysteine residue of AB, a lysine residue of AB, or a glutamine residue of AB.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 95.0
- Lexical Diversity: 1.17857
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14793942', '13670612', '14322262', '14069057', '15280563']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7711966280735191
- 35 USC 102 Novelty (BERT): 0.5332621386240184
- Combined Prediction Score: 0.747403179128569
- Mean Citation Score: 318.400396
- Max Citation Score: 330.31903
- Similarity Product: 217.00627529529453

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test